Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2004 Sep;80(947):527–534. doi: 10.1136/pgmj.2004.019356

Chorea and related disorders

R Bhidayasiri 1, D Truong 1
PMCID: PMC1743104  PMID: 15356354

Abstract

Chorea refers to irregular, flowing, non-stereotyped, random, involuntary movements that often possess a writhing quality referred to as choreoathetosis. When mild, chorea can be difficult to differentiate from restlessness. When chorea is proximal and of large amplitude, it is called ballism. Chorea is usually worsened by anxiety and stress and subsides during sleep. Most patients attempt to disguise chorea by incorporating it into a purposeful activity. Whereas ballism is most often encountered as hemiballism due to contralateral structural lesions of the subthalamic nucleus and/or its afferent or efferent projections, chorea may be the expression of a wide range of disorders, including metabolic, infectious, inflammatory, vascular, and neurodegenerative, as well as drug induced syndromes. In clinical practice, Sydenham's chorea is the most common form of childhood chorea, whereas Huntington's disease and drug induced chorea account for the majority of adult onset cases. The aim of this review is to provide an up to date discussion of this disorder, as well as a practical approach to its management.

Full Text

The Full Text of this article is available as a PDF (100.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albin R. L., Reiner A., Anderson K. D., Dure L. S., 4th, Handelin B., Balfour R., Whetsell W. O., Jr, Penney J. B., Young A. B. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol. 1992 Apr;31(4):425–430. doi: 10.1002/ana.410310412. [DOI] [PubMed] [Google Scholar]
  2. Asherson R. A., Derksen R. H., Harris E. N., Bouma B. N., Gharavi A. E., Kater L., Hughes G. R. Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. Semin Arthritis Rheum. 1987 May;16(4):253–259. doi: 10.1016/0049-0172(87)90003-5. [DOI] [PubMed] [Google Scholar]
  3. Bachoud-Lévi A. C., Rémy P., Nguyen J. P., Brugières P., Lefaucheur J. P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet. 2000 Dec 9;356(9246):1975–1979. doi: 10.1016/s0140-6736(00)03310-9. [DOI] [PubMed] [Google Scholar]
  4. Baxter L. R., Jr, Mazziotta J. C., Pahl J. J., Grafton S. T., St George-Hyslop P., Haines J. L., Gusella J. F., Szuba M. P., Selin C. E., Guze B. H. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiatry. 1992 Feb;49(2):148–154. doi: 10.1001/archpsyc.1992.01820020068009. [DOI] [PubMed] [Google Scholar]
  5. Bonuccelli U., Ceravolo R., Maremmani C., Nuti A., Rossi G., Muratorio A. Clozapine in Huntington's chorea. Neurology. 1994 May;44(5):821–823. doi: 10.1212/wnl.44.5.821. [DOI] [PubMed] [Google Scholar]
  6. Breedveld Guido J., van Dongen Jeroen W. F., Danesino Cesare, Guala Andrea, Percy Alan K., Dure Leon S., Harper Peter, Lazarou Lazarus P., van der Linde Herma, Joosse Marijke. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet. 2002 Apr 15;11(8):971–979. doi: 10.1093/hmg/11.8.971. [DOI] [PubMed] [Google Scholar]
  7. Bussone G., La Mantia L., Boiardi A., Giovannini P. Chorea in Behçet's syndrome. J Neurol. 1982;227(2):89–92. doi: 10.1007/BF00313774. [DOI] [PubMed] [Google Scholar]
  8. Cardoso Francisco. Chorea gravidarum. Arch Neurol. 2002 May;59(5):868–870. doi: 10.1001/archneur.59.5.868. [DOI] [PubMed] [Google Scholar]
  9. Cervera R., Asherson R. A., Font J., Tikly M., Pallarés L., Chamorro A., Ingelmo M. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997 May;76(3):203–212. doi: 10.1097/00005792-199705000-00006. [DOI] [PubMed] [Google Scholar]
  10. Chatterjee Anjan, Frucht Steven J. Tetrabenazine in the treatment of severe pediatric chorea. Mov Disord. 2003 Jun;18(6):703–706. doi: 10.1002/mds.10427. [DOI] [PubMed] [Google Scholar]
  11. Church A. J., Cardoso F., Dale R. C., Lees A. J., Thompson E. J., Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology. 2002 Jul 23;59(2):227–231. doi: 10.1212/wnl.59.2.227. [DOI] [PubMed] [Google Scholar]
  12. Conneally P. M. Huntington disease: genetics and epidemiology. Am J Hum Genet. 1984 May;36(3):506–526. [PMC free article] [PubMed] [Google Scholar]
  13. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997 Sep 26;277(5334):1990–1993. doi: 10.1126/science.277.5334.1990. [DOI] [PubMed] [Google Scholar]
  14. Dilenge M. E., Shevell M. I., Dinh L. Restricted unilateral Sydenham's chorea: reversible contralateral striatal hypermetabolism demonstrated on single photon emission computed tomographic scanning. J Child Neurol. 1999 Aug;14(8):509–513. doi: 10.1177/088307389901400805. [DOI] [PubMed] [Google Scholar]
  15. Emery E. S., Vieco P. T. Sydenham Chorea: magnetic resonance imaging reveals permanent basal ganglia injury. Neurology. 1997 Feb;48(2):531–533. doi: 10.1212/wnl.48.2.531. [DOI] [PubMed] [Google Scholar]
  16. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am. 1997 Jun;20(2):427–451. doi: 10.1016/s0193-953x(05)70321-x. [DOI] [PubMed] [Google Scholar]
  17. Fernandez M., Raskind W., Matsushita M., Wolff J., Lipe H., Bird T. Hereditary benign chorea: clinical and genetic features of a distinct disease. Neurology. 2001 Jul 10;57(1):106–110. doi: 10.1212/wnl.57.1.106. [DOI] [PubMed] [Google Scholar]
  18. Folstein S. E., Leigh R. J., Parhad I. M., Folstein M. F. The diagnosis of Huntington's disease. Neurology. 1986 Oct;36(10):1279–1283. doi: 10.1212/wnl.36.10.1279. [DOI] [PubMed] [Google Scholar]
  19. Gallo B. V., Shulman L. M., Weiner W. J., Petito C. K., Berger J. R. HIV encephalitis presenting with severe generalized chorea. Neurology. 1996 Apr;46(4):1163–1165. doi: 10.1212/wnl.46.4.1163. [DOI] [PubMed] [Google Scholar]
  20. Ghika-Schmid F., Ghika J., Regli F., Bogousslavsky J. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci. 1997 Mar 10;146(2):109–116. doi: 10.1016/s0022-510x(96)00290-0. [DOI] [PubMed] [Google Scholar]
  21. Grove V. E., Jr, Quintanilla J., DeVaney G. T. Improvement of Huntington's disease with olanzapine and valproate. N Engl J Med. 2000 Sep 28;343(13):973–974. doi: 10.1056/NEJM200009283431316. [DOI] [PubMed] [Google Scholar]
  22. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  23. Haerer A. F., Currier R. D., Jackson J. F. Hereditary nonprogressive chorea of early onset. N Engl J Med. 1967 Jun 1;276(22):1220–1224. doi: 10.1056/NEJM196706012762202. [DOI] [PubMed] [Google Scholar]
  24. Hahn-Barma V., Deweer B., Dürr A., Dodé C., Feingold J., Pillon B., Agid Y., Brice A., Dubois B. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):172–177. doi: 10.1136/jnnp.64.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Harper P. S. The epidemiology of Huntington's disease. Hum Genet. 1992 Jun;89(4):365–376. doi: 10.1007/BF00194305. [DOI] [PubMed] [Google Scholar]
  26. Hauser R. A., Furtado S., Cimino C. R., Delgado H., Eichler S., Schwartz S., Scott D., Nauert G. M., Soety E., Sossi V. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology. 2002 Mar 12;58(5):687–695. doi: 10.1212/wnl.58.5.687. [DOI] [PubMed] [Google Scholar]
  27. Higgins D. S., Jr Chorea and its disorders. Neurol Clin. 2001 Aug;19(3):707-22, vii. doi: 10.1016/s0733-8619(05)70041-4. [DOI] [PubMed] [Google Scholar]
  28. Honig M. G., Hume R. I. Carbocyanine dyes. Novel markers for labelling neurons. Trends Neurosci. 1989 Sep;12(9):336–338. [PubMed] [Google Scholar]
  29. Houser M. K., Soland V. L., Bhatia K. P., Quinn N. P., Marsden C. D. Paroxysmal kinesigenic choreoathetosis: a report of 26 patients. J Neurol. 1999 Feb;246(2):120–126. doi: 10.1007/s004150050318. [DOI] [PubMed] [Google Scholar]
  30. Huntington Study Group A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology. 2001 Aug 14;57(3):397–404. doi: 10.1212/wnl.57.3.397. [DOI] [PubMed] [Google Scholar]
  31. Hyde T. M., Hotson J. R., Kleinman J. E. Differential diagnosis of choreiform tardive dyskinesia. J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):255–268. doi: 10.1176/jnp.3.3.255. [DOI] [PubMed] [Google Scholar]
  32. Jarman Paul R., Wood Nicholas W. Genetics of movement disorders and ataxia. J Neurol Neurosurg Psychiatry. 2002 Dec;73 (Suppl 2):II22–II26. doi: 10.1136/jnnp.73.suppl_2.ii22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kaell A. T., Shetty M., Lee B. C., Lockshin M. D. The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients. Arch Neurol. 1986 Mar;43(3):273–276. doi: 10.1001/archneur.1986.00520030063016. [DOI] [PubMed] [Google Scholar]
  34. Kanazawa I. Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease. Neurogenetics. 1998 Dec;2(1):1–17. doi: 10.1007/s100480050046. [DOI] [PubMed] [Google Scholar]
  35. Koide R., Ikeuchi T., Onodera O., Tanaka H., Igarashi S., Endo K., Takahashi H., Kondo R., Ishikawa A., Hayashi T. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994 Jan;6(1):9–13. doi: 10.1038/ng0194-9. [DOI] [PubMed] [Google Scholar]
  36. Kooy R. F., Van der Veen A. Y., Verlind E., Houwen R. H., Scheffer H., Buys C. H. Physical localisation of the chromosomal marker D13S31 places the Wilson disease locus at the junction of bands q14.3 and q21.1 of chromosome 13. Hum Genet. 1993 Jun;91(5):504–506. doi: 10.1007/BF00217780. [DOI] [PubMed] [Google Scholar]
  37. Krauss J. K., Pohle T., Borremans J. J. Hemichorea and hemiballism associated with contralateral hemiparesis and ipsilateral basal ganglia lesions. Mov Disord. 1999 May;14(3):497–501. doi: 10.1002/1531-8257(199905)14:3<497::aid-mds1019>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  38. Lasker A. G., Zee D. S. Ocular motor abnormalities in Huntington's disease. Vision Res. 1997 Dec;37(24):3639–3645. doi: 10.1016/S0042-6989(96)00169-1. [DOI] [PubMed] [Google Scholar]
  39. McCusker E., Richards F., Sillence D., Wilson M., Trent R. J. Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing. J Clin Neurosci. 2000 Jan;7(1):38–41. doi: 10.1054/jocn.1998.0151. [DOI] [PubMed] [Google Scholar]
  40. McLellan D. L., Chalmers R. J., Johnson R. H. A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea. Lancet. 1974 Jan 26;1(7848):104–107. doi: 10.1016/s0140-6736(74)92338-1. [DOI] [PubMed] [Google Scholar]
  41. Naarding P., Kremer H. P., Zitman F. G. Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena. Eur Psychiatry. 2001 Dec;16(8):439–445. doi: 10.1016/s0924-9338(01)00604-6. [DOI] [PubMed] [Google Scholar]
  42. Nazabal E. R., Lopez J. M., Perez P. A., Del Corral P. R. Chorea disclosing deterioration of polycythaemia vera. Postgrad Med J. 2000 Oct;76(900):658–659. doi: 10.1136/pmj.76.900.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. O'Reilly S., Weber P. M., Oswald M., Shipley L. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper. Arch Neurol. 1971 Jul;25(1):28–32. doi: 10.1001/archneur.1971.00490010038005. [DOI] [PubMed] [Google Scholar]
  44. Ondo William G., Tintner Ron, Thomas Madhavi, Jankovic Joseph. Tetrabenazine treatment for Huntington's disease-associated chorea. Clin Neuropharmacol. 2002 Nov-Dec;25(6):300–302. doi: 10.1097/00002826-200211000-00003. [DOI] [PubMed] [Google Scholar]
  45. Oshima M., Osawa Y., Asano K., Saito T. Erythrocyte membrane abnormalities in patients with amyotrophic chorea with acanthocytosis. Part 1. Spin labeling studies and lipid analyses. J Neurol Sci. 1985 May;68(2-3):147–160. doi: 10.1016/0022-510x(85)90096-6. [DOI] [PubMed] [Google Scholar]
  46. Piccolo Immacolata, Defanti Carlo Alberto, Soliveri Paola, Volontè Maria Antonietta, Cislaghi Giuliana, Girotti Floriano. Cause and course in a series of patients with sporadic chorea. J Neurol. 2003 Apr;250(4):429–435. doi: 10.1007/s00415-003-1010-7. [DOI] [PubMed] [Google Scholar]
  47. Rosas H. D., Koroshetz W. J., Jenkins B. G., Chen Y. I., Hayden D. L., Beal M. F., Cudkowicz M. E. Riluzole therapy in Huntington's disease (HD). Mov Disord. 1999 Mar;14(2):326–330. doi: 10.1002/1531-8257(199903)14:2<326::aid-mds1019>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  48. Ross C. A., Margolis R. L., Rosenblatt A., Ranen N. G., Becher M. W., Aylward E. Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltimore) 1997 Sep;76(5):305–338. doi: 10.1097/00005792-199709000-00001. [DOI] [PubMed] [Google Scholar]
  49. Schoenfeld M., Myers R. H., Cupples L. A., Berkman B., Sax D. S., Clark E. Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry. 1984 Dec;47(12):1283–1287. doi: 10.1136/jnnp.47.12.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Schrag A., Quinn N. P., Bhatia K. P., Marsden C. D. Benign hereditary chorea--entity or syndrome? Mov Disord. 2000 Mar;15(2):280–288. doi: 10.1002/1531-8257(200003)15:2<280::aid-mds1011>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  51. Schwartz A., Hennerici M., Wegener O. H. Delayed choreoathetosis following acute carbon monoxide poisoning. Neurology. 1985 Jan;35(1):98–99. doi: 10.1212/wnl.35.1.98. [DOI] [PubMed] [Google Scholar]
  52. Snell R. G., MacMillan J. C., Cheadle J. P., Fenton I., Lazarou L. P., Davies P., MacDonald M. E., Gusella J. F., Harper P. S., Shaw D. J. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet. 1993 Aug;4(4):393–397. doi: 10.1038/ng0893-393. [DOI] [PubMed] [Google Scholar]
  53. Stevenson V. L., Hardie R. J. Acanthocytosis and neurological disorders. J Neurol. 2001 Feb;248(2):87–94. doi: 10.1007/s004150170241. [DOI] [PubMed] [Google Scholar]
  54. Swedo S. E. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994 Dec 14;272(22):1788–1791. doi: 10.1001/jama.272.22.1788. [DOI] [PubMed] [Google Scholar]
  55. Vernino Steven, Tuite Paul, Adler Charles H., Meschia James F., Boeve Bradley F., Boasberg Peter, Parisi Joseph E., Lennon Vanda A. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002 May;51(5):625–630. doi: 10.1002/ana.10178. [DOI] [PubMed] [Google Scholar]
  56. Vital A., Bouillot S., Burbaud P., Ferrer X., Vital C. Chorea-acanthocytosis: neuropathology of brain and peripheral nerve. Clin Neuropathol. 2002 Mar-Apr;21(2):77–81. [PubMed] [Google Scholar]
  57. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., Richardson E. P., Jr Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985 Nov;44(6):559–577. doi: 10.1097/00005072-198511000-00003. [DOI] [PubMed] [Google Scholar]
  58. Yen D. J., Shan D. E., Lu S. R. Hyperthyroidism presenting as recurrent short paroxysmal kinesigenic dyskinesia. Mov Disord. 1998 Mar;13(2):361–363. doi: 10.1002/mds.870130231. [DOI] [PubMed] [Google Scholar]
  59. du Plessis Adré J., Bellinger David C., Gauvreau Kimberlee, Plumb Christine, Newburger Jane W., Jonas Richard A., Wessel David L. Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery. Pediatr Neurol. 2002 Jul;27(1):9–17. doi: 10.1016/s0887-8994(02)00382-x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Erratum]
postmedj_80_947_527__index.html (726B, html)

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES